AIF translocates to the nucleus in the spinal motor neurons in a mouse model of ALS

Neuroscience Letters

Volumn 406, Issue 3, 2006, Pages 205-210

  Oh, Yeo Kyoung ^a   Shin, Ki Soon ^b   Kang, Shin Jung ^a  

^a Sejong University   (South Korea)

^b Kyung Hee University   (South Korea)

Author keywords

Amyotrophic lateral sclerosis; Apoptosis inducing factor; Motor neuron; Neurodegeneration

Indexed keywords

APOPTOSIS INDUCING FACTOR; CASPASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN MITOCHONDRION; CELL DEATH; CELL NUCLEUS; CHEMICAL ANALYSIS; CONFOCAL MICROSCOPY; DISEASE COURSE; MOTONEURON; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SYMPTOM; TRANSGENIC MOUSE;

AGE FACTORS; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; APOPTOSIS INDUCING FACTOR; BLOTTING, WESTERN; CELL NUCLEUS; DISEASE MODELS, ANIMAL; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; MOTOR NEURONS; PROTEIN TRANSPORT; SPINAL CORD; SUPEROXIDE DISMUTASE;

EID: 33748145128     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.07.044     Document Type: Article

References (22)

1. Bruijn L.I., Miller T.M., and Cleveland D.W. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci. 27 (2004) 723-749
2. Cande C., Cecconi F., Dessen P., and Kroemer G. Apoptosis-inducing factor (AIF): key to the conserved caspase-independent pathways of cell death?. J. Cell Sci. 115 (2002) 4727-4734
3. Cao G., Clark R.S., Pei W., Yin W., Zhang F., Sun F.Y., Graham S.H., and Chen J. Translocation of apoptosis-inducing factor in vulnerable neurons after transient cerebral ischemia and in neuronal cultures after oxygen-glucose deprivation. J. Cereb. Blood Flow Metab. 23 (2003) 1137-1150
4. Chu C.T., Zhu J.H., Cao G., Signore A., Wang S., and Chen J. Apoptosis inducing factor mediates caspase-independent 1-methyl-4-phenylpyridinium toxicity in dopaminergic cells. J. Neurochem. 94 (2005) 1685-1695
5. Chung Y.H., Joo K.M., Lee Y.J., Shin D.H., and Cha C.I. Reactive astrocytes express PARP in the central nervous system of SOD (G93A) transgenic mice. Brain Res. 1003 (2004) 199-204
6. Ge W.W., Wen W., Strong W., Leystr-Lantz C., and Strong M.J. Mutant copper-zinc superoxide dismutase binds to and destabilizes human low molecular weight neurofilament mRNA. J. Biol. Chem. 280 (2005) 118-124
7. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., and Deng H.X. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264 (1994) 1772-1775
8. Ha H.C. Defective transcription factor activation for proinflammatory gene expression in poly(ADP-ribose) polymerase 1-deficient glia. Proc. Natl. Acad. Sci. 101 (2004) 5087-5092
9. Hong S.J., Dawson T.M., and Dawson V.L. Nuclear and mitochondrial conversations in cell death: Parp-1 and AIF signaling. Trends Pahrmacol. Sci. 25 (2004) 259-264
10. Kang S.J., Sanchez I., Jing N., and Yuan J. Dissociation between neurodegeneration and caspase-11-mediated activation of caspase-1 and caspase-3 in a mouse model of amyotrophic lateral sclerosis. J. Neurosci. 23 (2003) 5455-5460
11. Kang S.J., Wang S., Hara H., Peterson E.P., Namura S., Amin-Hanjani S., Huang Z., Srinivasan A., Tomaselli K.J., Thornberry N.A., Moskowitz M.A., and Yuan J. Dual role of caspase-11 in mediating activation of caspase-1 and caspase-3 under pathological conditions. J. Cell Biol. 149 (2000) 613-622
12. Kim S.H., Henkel J.S., Beers D.R., Simpson I.S., Goodman J.C., Engelhardt J.I., Siklos L., and Appel S.H. PARP expression is increased in astrocytes but decreased in motor neurons in the spinal cord of sporadic ALS patients. J. Neuropathol. Exp. Neurol. 62 (2003) 88-103
13. Klein J.A., Longo-Guess C.M., Rossmann M.P., Seburn K.L., Hurd R.E., Frankel W.N., Bronson R.T., and Ackerman S.L. The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature 419 (2002) 367-374
14. Migheli A., Atzori C., Piva R., Tortarolo M., Girelli M., Schiffer D., and Bendotti C. Lack of apoptosis in mice with ALS. Nature Med. 5 (1999) 966-967
15. Prezedborski S. Programmed cell death in amyotrophic lateral sclerosis: a mechanism of pathogenic and therapeutic importance. Neurologist 10 (2004) 1-7
16. Rao M.V., and Nixon R.A. Defective neurofilament transport in mouse models of amyotrophic lateral sclerosis: a review. Neurochem. Res. 28 (2003) 1041-1047
17. Strong M.J., Kesavapany S., and Pant H.C. The pathobiology of amyotrophic lateral sclerosis: a proteinopathy?. J. Neuropathol. Exp. Neurol. 64 (2005) 649-664
18. Tomik B., Adamek D., Pierzchalski P., Banares S., Duda A., Paryka D., Pawlik W., Katuza J., Krajewski S., and Szczudlik A. Does apoptosis occur in amyotrophic lateral sclerosis? TUNEL experience from human Amyotrophic Lateral Sclerosis (ALS) tissues. Folia Neuropathol. 43 (2005) 75-80
19. Valentine J.S., Doucette P.A., and Potter S.Z. Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis. Annu. Rev. Biochem. 74 (2005) 563-593
20. Yamazaki M., Esumi E., and Nakano I. Is motor neuronal cell death in amyotrophic lateral sclerosis apoptosis?. Neuropathology 25 (2005) 381-387
21. Yuste V.J., Sanchez-Lopez I., Sole C., Moubarak R.S., Bayascas J.R., Dolcet X., Encinas M., Susin S.A., and Comella J.X. The contribution of apoptosis-inducing factor, caspase-activated DNase, and inhibitor of caspase-activated DNase to the nuclear phenotype and DNA degradation during apoptosis. J. Biol. Chem. 280 (2005) 35670-35683
22. Zhang X., Chen J., Graham S.H., Du L., Kochanek P.M., Draviam R., Guo F., Nathaniel P.D., Szabo C., Watkins S.C., and Clark R.S. Intranuclear localization of apoptosis-inducing factor (AIF) and large scale DNA fragmentation after traumatic brain injury in rats and in neuronal cultures exposed to peroxynitrite. J. Neurochem. 82 (2002) 181-191